Tag: ActRII
-
How HM17321 Could Preserve Muscle During Weight Loss
HM17321 uses UCN2–CRFR2 signaling to target fat loss and muscle preservation through a non-incretin mechanism, offering a different approach to obesity treatment.
HM17321 uses UCN2–CRFR2 signaling to target fat loss and muscle preservation through a non-incretin mechanism, offering a different approach to obesity treatment.